APA (7th ed.) Citation

A, K., JC, L., EV, C., C, T., A, C., C, P., . . . EJ, M. (2026). VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines. Science translational medicine, 18(848), eadr4509. https://doi.org/10.1126/scitranslmed.adr4509

Chicago Style (17th ed.) Citation

A, Khaitan, et al. "VRC01 with Antiretroviral Initiation in Infants Is Well Tolerated, and Higher Concentrations Associate with Greater HIV-1 DNA Declines." Science Translational Medicine 18, no. 848 (2026): eadr4509. https://doi.org/10.1126/scitranslmed.adr4509.

MLA (9th ed.) Citation

A, Khaitan, et al. "VRC01 with Antiretroviral Initiation in Infants Is Well Tolerated, and Higher Concentrations Associate with Greater HIV-1 DNA Declines." Science Translational Medicine, vol. 18, no. 848, 2026, p. eadr4509, https://doi.org/10.1126/scitranslmed.adr4509.